Videos

Video of American Society of Echocardiography (ASE) leadership explaining how the society recognized early the need for standardization and training for on and stepped forward to offer training for various point of care ultrasound (POCUS) users and to bring them into its membership. Image shows a critical care COVID patient being scanned with a Philips Lumify point-of-care ultrasound system with doctors on screen helping guide the user. #POCUS #ASE #ASE2023

ASE training clinicians as point-of-care ultrasound grows

The American Society of Echocardiography recognized the lack of training and standardization for point-of-care ultrasound users and decided to do something about it. 

Roosha Parikh, MD, advanced imaging cardiologist, St. Francis Heart Hospital, Long Island, New York, and a clinical assistant professor of medicine at the State University of New York at Stony Brook, presented in one of the ASE 2023 amyloid sessions and spoke with Cardiovascular Business about the disease.

Amyloidosis now a hot topic in cardiac imaging due to new drug treatment

Advanced cardiac imager Roosha Parikh, MD, explained that cardiac amyloidosis is regularly misdiagnosed. It can often be identified in echocardiography results, however, if physicians know how to identify it. 

Stephen Little, MD, discusses trends in echocardiography at ASE 2023. #ASE23 #ASE2023 What is new in cardiac ultrasound.

Back in the spotlight: Exploring echocardiography's revival

American Society of Echocardiography President Stephen Little, MD, says several trends and technologies are coming together at once, leading to renewed interest in echo.

Roberto Lang, MD, explains how AI can help novice users get diagnostic quality cardiac echo exams at ASE 2023.#ASE #AI #ASE2023

AI can help novice sonographers deliver optimal echocardiograms

Roberto Lang, MD, has been closely involved with the development of AI technology that helps inexperienced ultrasound users perform high-quality echo exams. "It is an unbelievable thing when you see it working," he said. 

Ted Abraham, MD, explains ASE efforts to increase HCM education and standardization of care. #HCM #ASE #ASE23 #ASE2023

All eyes are on hypertrophic cardiomyopathy now that a drug treatment is in place

Ted Abraham, MD, explained why HCM has entered the limelight at recent cardiology conferences, including ASE 2023.

James Kirkpatrick, MD, explains the key trends at ASE 2023. #ASE23 #ASE2023

Key takeaways in cardiac ultrasound from ASE 2023

James Kirkpatrick, MD, discussed some of the biggest trends and themes he saw at the American Society of Echocardiography's 2023 annual meeting.

The U.S. Food and Drug Administration (FDA) priority review, the FDA has cleared the Agepha Pharma USA LLC's drug Lodoco (colchicine) as the first anti-inflammatory atheroprotective cardiovascular treatment.

FDA approves colchicine, the first anti-inflammatory drug for treating cardiovascular disease

The FDA's approval of colchicine, which is marketed and sold under the name Lodoco, is expected to have a big impact on cardiac care and outcomes.

Radiology IT expert Rik Primo explains issues with interfacing EMR data into radiology PACS. #interoperability #PACS

Improving interoperability between the PACS and EMR

Radiologists need better access to patient data stored in the electronic medical record, imaging IT expert Rik Primo explains.